Department of Gastroenterology & Hepatology
Basel, Basel-Stand, 4031, Switzerland
NCT Number: NCT00920400
Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neoplasias, and infectious gastroenteritis. Elevated calprotectin levels can also be found in patients with lesion only in the upper gastrointestinal tract. However, the diagnostic value of calprotectin has never been tested in this setting. The aim of the study is therefore to determine the diagnostic value of fecal calprotectin in patients with diseases of the upper gastrointestinal tract.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Basel, Basel-Stand, 4031, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Hospital, Basel, Switzerland
Other
Value of Fecal Calprotectin in Upper Gastrointestinal Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04693780
Colonic Diseases, Colonic Diseases, Functional
Hamilton, Ontario, Canada
View Trial DetailsNCT04879914
Colonic Diseases, Colonic Diseases, Functional
Padua, Italy
View Trial DetailsNCT03082287
Colonic Diseases, Colonic Diseases, Functional
Salem, New Hampshire, United States
View Trial DetailsNCT03143517
Abdominal Pain, Body Weight
Dothan, Alabama, United States
View Trial Details